A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
Research Initiative
|
FDA
|
NCI
|
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and prostate cancer
|
Research Initiative
|
CDC
|
|
2020
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and renal cell carcinoma
|
Research Initiative
|
CDC
|
|
2018
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and uterine and ovarian cancers
|
Research Initiative
|
CDC
|
|
2019
|
|
A nested case-control study of serum PFAS and testicular cancer in Air Force servicemen
|
Research Initiative
|
CDC
|
|
2019
|
|
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
|
Research Initiative
|
CDC
|
|
1998
|
|
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Working Group to Consider the Question of Federal Public Health and Medical Resource Allocation
|
Committee, Advisory Group, or Work Group
|
OS
|
|
2011
|
|
A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial
|
Research Initiative
|
CDC
|
NIAID
|
2015
|
|
A5418: Study of Tecovirimat For Human Monkeypox Virus (STOMP)
|
Other
|
CDC, FDA
|
NIAID
|
2022
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Therapeutics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-1: Immune Modulators (ACTIV-1)
|
Research Initiative
|
FDA, ASPR
|
NCATS
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-6: Outpatient Repurposed Drugs (ACTIV-6)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID, NHLBI, NCATS
|
2021
|
|
Accelerating Medicines Partnership (AMP)
|
Other
|
FDA
|
NIA, NIDDK, NIAMS, NINDS, NIMH
|
2014
|
|
Accelerating Medicines Partnership® Schizophrenia (AMP SCZ)
|
Research Initiative
|
FDA
|
|
2020
|
|
AccessGUDID
|
Resource Development
|
FDA, GDM
|
|
2015
|
|
ACL Advisory Council on Grandparents Raising Grandchildren
|
Committee, Advisory Group, or Work Group
|
ACL, ACF, SAMHSA, CDC, HRSA, ASPE, ONC
|
|
2019
|
|
Adaptive Optics Imaging of Outer Retinal Diseases
|
Research Initiative
|
FDA
|
|
|
|
Adaptive Optics Retinal Imaging
|
Research Initiative
|
FDA
|
NEI
|
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA, ASPR
|
NCI, NIAID
|
2013
|
|
Adolescent Brain Cognitive Development (ABCD) Study
|
Research Initiative
|
CDC
|
NCI, NIAAA, NICHD, NIDA, NIMH, NIMHD, NINDS, OD/ DPCPSI/ OBSSR
|
2016
|
|
Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
|
|
Adolescent Human Immunodeficiency Virus (HIV) Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
2016
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Advanced Viral Detection Technology IG (AVDTIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2018
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA, ASPE, ASPR, HRSA, IHS, OCR
|
NIEHS, NIDDK
|
2019
|
|
Advancing Protection and Care for Children in Adversity: A U.S. Government Strategy for International Assistance (APCCA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NICHD, NIMH
|
2019
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHGRI, NHLBI, NICHD, NIDDK, NLM
|
2015
|
|
Advisory Committee on Immunization Practices (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
|
|
Advisory Committee on Maternal/Pediatric RSV Vaccines (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, HRSA, IHS, CMS
|
NIAID
|
2022
|
|
Advisory Committee on Organ Transplantation (ACOT)
|
Committee, Advisory Group, or Work Group
|
HRSA, OS
|
NIAID
|
2009
|
|
Advisory Committee on RSV Vaccines in Older Adults (ACIP WG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH, CMS
|
|
2022
|
|
Advisory Council on Blood Stem Cell Transplantation (ACBSCT) of the U.S. Department of Health and Human Services (HHS)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA
|
NHLBI
|
2008
|
|
Agency Priority Goals Maternal Health
|
Committee, Advisory Group, or Work Group
|
HRSA, NIH, ASPE, CDC, CMS, FDA, OASH, ACF, OGA, AHRQ, ACL
|
OD/ DPCPSI/ ORWH, NICHD, OD/ IMOD, OD/ DPCPSI/ OEPR
|
2022
|
|
Alaska Native Tumor Registry
|
Resource Development
|
CDC, IHS
|
|
1999
|
|
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
|
Research Initiative
|
FDA
|
NIAAA
|
|
|
All of Us IAA with CDC Office of Public Health Genomics
|
Other
|
CDC
|
|
2021
|
|
Alzheimers.gov Collaborations with Federal Agencies
|
Public Education Campaign
|
ACL, ASPA, ASPE, CDC
|
NIA, NINDS
|
2020
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Nutrition
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Pediatric AIDS (AAP-COPA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Council on Genetics (AAP-COG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Section on Obesity (AAP-SOO)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics Council on Injury, Violence and Poison Prevention (AAP-COIVPP)
|
Committee, Advisory Group, or Work Group
|
ACF, HRSA, IHS
|
NICHD
|
2011
|
|
American Community Survey (ACS) Interagency Committee Meeting
|
Meeting/ Workshop
|
ACF, AHRQ, ASPE, CDC, CMS, HRSA
|
NICHD
|
|
|
American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
Americas Children Forum on Health and Family Statistics
|
Resource Development
|
SAMHSA
|
NIDA
|
1994
|
|
AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC)
|
Research Initiative
|
FDA
|
NCATS, NHLBI, NIMH, NINDS
|
2019
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Analytical Methods and Reference Materials Program (AMRM)
|
Resource Development
|
FDA
|
NCCIH, NCI, NIDDK
|
2002
|
|
Ancillary Swab Study to PREVENT-19 trial: Swab your Nose Inside to Find inFection (SNIFF)
|
Research Initiative
|
ASPR, CDC, FDA
|
|
2021
|
|
Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ, CDC
|
FIC, NHGRI, NHLBI, NIAAA, NIDA, NIDDK, NIMH, NIMHD, NINR, NIEHS, OD
|
2014
|
|
Antibody Interest Group (ABIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI, NIAID, NIDCR, NIDDK
|
2010
|
|
Antimicrobial Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2007
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC
|
NICHD
|
1989
|
|
Antiviral Program for Pandemics
|
Research Initiative
|
ASPR
|
NIAID, NCATS, OD/ DPCPSI/ ORIP
|
2020
|
|
Arthritis Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
Assay optimization and screening for measuring the kinetics of antibacterial resistance emergence
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Assay subgroup for SARS-CoV-2
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, BARDA, FDA
|
NIAID
|
2020
|
|
Assessing the Burden of Diabetes by Type in Children, Adolescents, and Young Adults Network (DiCAYA)
|
Resource Development
|
CDC
|
|
2020
|
|
Assessment of Inhalation Exposures to Indoor and Occupational Aerosols
|
Research Initiative
|
CDC
|
NIEHS
|
2014
|
|
Assessment of task-based exposures that may affect reproductive health in nail salon employees
|
Research Initiative
|
CDC
|
|
2021
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
|